PERFUSE: A FRENCH PROSPECTIVE/RETROSPECTIVE NON-INTERVENTIONAL COHORT STUDY OF INFLIXIMAB-NAIIVE AND TRANSITIONED PATIENTS RECEIVING INFLIXIMAB BIOSIMILAR SB2; AN INTERIM ANALYSIS

被引：3
|
作者：
Fautrel, B. [1 ]
Bouhnik, Y. [2 ]
Desjeux, G. [3 ]
Brigui, A. [4 ]
Freudensprung, U. [5 ]
Addison, J. [6 ]
机构：
[1] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Paris, France
[2] Paris Diderot Univ, Beaujon Hosp, AP HP, Clichy, France
[3] E Hlth Serv Sanoia, Gemenos, France
[4] Biogen France SAS, Paris, France
[5] Biogen GmbH, Baar, Switzerland
[6] Biogen Idec Inc, Maidenhead, Berks, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.5682
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0164
引用
收藏
页码：293 / 294
页数：2
相关论文
共 50 条
  • [1] PERFUSE: A French Prospective/Retrospective Non-interventional Cohort Study of Infliximab-naive and Transitioned Patients Receiving Infliximab Biosimilar SB2; An Interim Analysis
    Fautrel, Bruno
    Bouhnik, Yoram
    Desjeux, Guillaume
    Freudensprung, Ulrich
    Addison, Janet
    Brigui, Amira
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [2] PERFUSE: A french non-interventional cohort study of infliximab-naive and transitioned patients receiving infliximab biosimilar SB2; An interim analysis
    Bouhnik, Y.
    Fautrel, B.
    Desjeux, G.
    Freudensprung, U.
    Brigui, A.
    Addison, J.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S529 - S529
  • [3] PERFUSE: Non-Interventional Cohort Study of Patients Receiving Infliximab Biosimilar SB2: Results in Pediatric Patients
    Martinez-Vinson, Christine
    Lemoine, Anais
    Bouhnik, Yoram
    Braithwaite, Ben
    Fohlen-Weill, Audrey
    Addison, Janet
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 76 (04): : 451 - 459
  • [4] PERFUSE: A FRENCH PROSPECTIVE/RETROSPECTIVE NONINTERVENTIONAL COHORT STUDY OF INFLIXIMAB-NAIVE AND TRANSITIONED PATIENTS RECEIVING INFLIXIMAB BIOSIMILAR SB2; 12-MONTH ANALYSIS
    Fautrel, B.
    Bouhnik, Y.
    Dougados, M.
    Freudensprung, U.
    Addison, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 544 - 544
  • [5] PERFUSE: a French non-interventional study of patients with inflammatory bowel disease receiving infliximab biosimilar SB2: a 12-month analysis
    Bouhnik, Yoram
    Fautrel, Bruno
    Beaugerie, Laurent
    Pelletier, Anne-Laure
    Martinez-Vinson, Christine
    Freudensprung, Ulrich
    Brigui, Amira
    Addison, Janet
    PERFUSE investigators
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [6] SPOSIB SB2: A Sicilian prospective observational study of patients with inflammatory bowel disease treated with infliximab Biosimilar SB2 (Flixabi®): interim analysis
    Macaluso, F. S.
    Cappello, M.
    Giuffrida, E.
    Fries, W.
    Centritto, A.
    Privitera, A. C.
    Inserra, G.
    Vassallo, R.
    Magnano, A.
    Vinci, E.
    Garufi, S.
    Ventimiglia, M.
    Renna, S.
    Orlando, R.
    Rizzuto, G.
    Cottone, M.
    Orlando, A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S490 - S490
  • [7] Real-world evidence of the use of the infliximab biosimilar SB2: data from the PERFUSE study
    Fautrel, Bruno
    Bouhnik, Yoram
    Dieude, Philippe
    Richette, Pascal
    Dougados, Maxime
    Freudensprung, Ulrich
    Brigui, Amira
    Addison, Janet
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2023, 7 (02)
  • [8] SPOSIB SB2-A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB BIOSIMILAR SB2 (FLIXABI®): INTERIM ANALYSIS
    Macaluso, F. S.
    Cappello, M.
    Giuffrida, E.
    Fries, W.
    Centritto, A.
    Privitera, A. C.
    Inserra, G.
    Vassallo, R.
    Magnano, A.
    Vinci, E.
    Garufi, S.
    Ventimiglia, M.
    Renna, S.
    Orlando, R.
    Rizzuto, G.
    Cottone, M.
    Orlando, A.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E110 - E110
  • [9] SPOSIB SB2: a Sicilian prospective observational study of patients with inflammatory bowel disease treated with infliximab biosimilar SB2
    Macaluso, F. S.
    Fries, W.
    Viola, A.
    Centritto, A.
    Cappello, M.
    Giuffrida, E.
    Privitera, A. C.
    Piccillo, G.
    Magnano, A.
    Vinci, E.
    Vassallo, R.
    Trovatello, A.
    Belluardo, N.
    Giangreco, E.
    Camilleri, S.
    Garufi, S.
    Bertolami, C.
    Ventimiglia, M.
    Renna, S.
    Orlando, R.
    Rizzuto, G.
    Grova, M.
    Orlando, A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S387 - S388
  • [10] Letter: SPOSIB SB2-a Sicilian prospective observational study of IBD patients treated with infliximab biosimilar SB2
    Macaluso, Fabio Salvatore
    Cappello, Maria
    Giuffrida, Enrica
    Fries, Walter
    Centritto, Andrea
    Privitera, Antonio Carlo
    Inserra, Gaetano
    Vassallo, Roberto
    Magnano, Antonio
    Vinci, Elisa
    Garufi, Serena
    Ventimiglia, Marco
    Renna, Sara
    Orlando, Rosalba
    Rizzuto, Giulia
    Cottone, Mario
    Orlando, Ambrogio
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (02) : 234 - 236
12345